Shenzhen Weiguang Biological Products Balance Sheet Health
Financial Health criteria checks 5/6
Shenzhen Weiguang Biological Products has a total shareholder equity of CN¥2.1B and total debt of CN¥655.4M, which brings its debt-to-equity ratio to 31.3%. Its total assets and total liabilities are CN¥3.0B and CN¥940.8M respectively. Shenzhen Weiguang Biological Products's EBIT is CN¥242.3M making its interest coverage ratio 23.8. It has cash and short-term investments of CN¥358.6M.
Key information
31.3%
Debt to equity ratio
CN¥655.44m
Debt
Interest coverage ratio | 23.8x |
Cash | CN¥358.64m |
Equity | CN¥2.09b |
Total liabilities | CN¥940.83m |
Total assets | CN¥3.03b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 002880's short term assets (CN¥1.3B) exceed its short term liabilities (CN¥328.9M).
Long Term Liabilities: 002880's short term assets (CN¥1.3B) exceed its long term liabilities (CN¥612.0M).
Debt to Equity History and Analysis
Debt Level: 002880's net debt to equity ratio (14.2%) is considered satisfactory.
Reducing Debt: 002880's debt to equity ratio has increased from 0.4% to 31.3% over the past 5 years.
Debt Coverage: 002880's debt is well covered by operating cash flow (51.1%).
Interest Coverage: 002880's interest payments on its debt are well covered by EBIT (23.8x coverage).